02.25.25 -- January 2025 — CDMO Opportunities And Threats Report

Depending on the protein or peptide of interest for your therapeutic and manufacturing goals, there are a number of different approaches that can prove advantageous. Learn more about these various methods.

The complex nature of ADCs necessitates meticulous attention to CMC. Gain valuable insights for navigating CMC development, ensuring the delivery of safe and efficacious biopharmaceutical products.

A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.

Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

Immune cell therapies have incredible potential for cancer treatment, and making them more cost effective is a critical consideration for improving patient access and outcomes.

Facing challenges transferring your biological product from development to manufacturing? Delve into strategies for tech transfer processes, ensuring regulatory compliance, quality, and consistency.

PMs must be technically adept enough to understand a project, but their main role is to ensure it delivers in terms of scope and budget.